Contracts Finder · Award
IREFER / CDS LICENCE
A public procurement published by East Sussex Healthcare NHS Trust via Contracts Finder.
- £196.7k
- Award value
- £136.2k
- Tender value
- 1
- Suppliers
- 1
- Awards
- 1
- Notices
- Award
- Stage
Overview
MedCurrent iRefer CDS Software is a Clinical Decision Support (CDS) cloud hosted Software-as-a-Service solution. Solution leverages Royal College of Radiologists (RCR) iRefer Referral guidelines. The Solution integrates to existing Electronic Health Record (EHR) systems using healthcare interoperability standards. Additional information: This is a call off contract from framework G-Cloud 14 Framework Agreement (RM1557.14)
Key details
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 48180000 — Medical software package
- Currency
- GBP
- Total award value
- £196,699
- Tender value
- £136,193
- First published
- 26 Feb 2026
- Last updated
- 26 Feb 2026
Awards
1 award recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| MedCurrent UK Ltd | SC590606 | 24 Feb 2026 | active | £196.7k |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
FAQs about this procurement
Who is the buyer for "IREFER / CDS LICENCE"?
IREFER / CDS LICENCE is a UK public-sector procurement published by East Sussex Healthcare NHS Trust via Contracts Finder.
Has "IREFER / CDS LICENCE" been awarded?
Yes — 1 award is recorded, with a reported total value of £196,699. The current lifecycle stage is "Award".
Which suppliers are involved in "IREFER / CDS LICENCE"?
1 supplier is linked: MedCurrent UK Ltd.
What is "IREFER / CDS LICENCE" worth?
The reported award value is £196,699.
When was "IREFER / CDS LICENCE" published?
It was first published on 26 Feb 2026 and last updated on 26 Feb 2026, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable